Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 1125 of 1475 entries
View as:

BMS-741672 for Diabetic Neuropathic Pain

Phase: N/A Priority: Normal
NCT ID: NCT00683423 Org: User:
Start: 07/31/08 End: 02/28/09 Due: 02/28/10

Effectiveness and Safety of Two Forms of Stavudine in HIV-Infected Patients

Phase: N/A Priority: Normal
NCT ID: NCT00005918 Org: User:
Start: 06/30/00 End: 04/30/02 Due: 04/30/03

Head and Neck Cancer Treatment Patterns and Outcomes Research Study in France, Germany, and Canada

Phase: N/A Priority: Normal
NCT ID: NCT02705833 Org: User:
Start: 12/31/15 End: 12/06/16 Due: 12/06/17

Safety Study of Abatacept to Treat Rheumatoid Arthritis (A)

Phase: N/A Priority: Normal
NCT ID: NCT01088321 Org: User:
Start: 03/31/05 End: 11/30/16 Due: 11/30/17

BMS-354825 in Patients With Chronic Accelerated, or Blast Phase Chronic Myelogenous Leukemia or Philadelphia Positive Acute Lymphoblastic Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT00103701 Org: User:
Start: 11/30/03 End: 03/31/06 Due: 03/31/07

Expanded Access for Bromodomain and Extra-Terminal (BET) Inhibitor

Phase: N/A Priority: Normal
NCT ID: NCT05301972 Org: User:
Start: - End: - Due: -

A Study to Evaluate the Bioavailability of Fedratinib When Administered in Different Ways to Healthy Adult Participants

Phase: N/A Priority: Normal
NCT ID: NCT05051553 Org: User:
Start: 09/21/21 End: 04/08/22 Due: 04/08/23

MDX-060 in Patients With Relapsed or Refractory Classic Systemic or Primary Cutaneous Anaplastic Large Cell Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT00298467 Org: User:
Start: 02/28/06 End: - Due: -

A Study of Experimental Medication BMS-986278 Given to Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT03429933 Org: User:
Start: 02/07/18 End: 03/02/19 Due: 03/02/20

An Investigational Immuno-therapy Study of Nivolumab, Compared to Placebo, in Patients With Bladder or Upper Urinary Tract Cancer, Following Surgery to Remove the Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02632409 Org: User:
Start: 03/22/16 End: 05/27/27 Due: 05/27/28

Comparing the Effectiveness of a Treat-to-target (T2T) Disease Management Strategy vs. Routine Care (RC) in Adult Patients With Moderate to Severe Rheumatoid Arthritis (RA) Treated With Subcutaneous Abatacept (Orencia - SC)

Phase: N/A Priority: Normal
NCT ID: NCT03274141 Org: User:
Start: 10/31/11 End: 10/31/18 Due: 10/31/19

COLLIGO-HCM: A Multinational Observational Study of the Real-World Effectiveness of Mavacamten Among Patients With Symptomatic Obstructive Hypertrophic Cardiomyopathy (oHCM)

Phase: N/A Priority: Normal
NCT ID: NCT06372457 Org: User:
Start: 12/01/23 End: 06/15/25 Due: 06/15/26

A Study to Evaluate the Effect of Co-administration of Itraconazole or Diltiazem on the Single-dose of Danicamtiv in Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT05162222 Org: User:
Start: 12/15/21 End: 07/08/22 Due: 07/08/23

Abatacept in the Treatment and Prevention of Active Systemic Lupus Erythematosus (SLE) Flares in Combination With Prednisone

Phase: N/A Priority: Normal
NCT ID: NCT00119678 Org: User:
Start: 09/30/05 End: 11/30/08 Due: 11/30/09

Healthcare Cost and Resource Utilization Related to Metastatic Renal Cell Carcinoma Treatment With Intravenous and Oral Agents

Phase: N/A Priority: Normal
NCT ID: NCT02928263 Org: User:
Start: 02/28/17 End: 05/31/17 Due: 05/31/18

Study of Drug Combination on Pharmacokinetics in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02175602 Org: User:
Start: 06/30/14 End: - Due: -

A Study of BMS-833923 With Cisplatin and Capecitabine in Inoperable, Metastatic Gastric, Gastroesophageal, or Esophageal Adenocarcinomas

Phase: N/A Priority: Normal
NCT ID: NCT00909402 Org: User:
Start: 11/30/09 End: 11/30/12 Due: 11/30/13

Study of MDX-010 in Patients With Metastatic Hormone-Refractory Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00323882 Org: User:
Start: 01/31/06 End: 07/31/13 Due: 07/31/14

BMS-Reyataz Study in Treatment in Naive Subjects to Compare the Efficacy and Safety Between Boosted Reyataz and Kaletra When in Combination With Fixed Dose Truvada

Phase: N/A Priority: Normal
NCT ID: NCT00272779 Org: User:
Start: 11/30/05 End: 10/31/08 Due: 10/31/09

Abatacept and Infliximab in Combination With Methotrexate in Subjects With Rheumatoid Arthritis

Phase: N/A Priority: Normal
NCT ID: NCT00095147 Org: User:
Start: 02/28/05 End: 07/31/09 Due: 07/31/10

Rollover Study of Weekly Paclitaxel (BMS-181339) in Patients With Head and Neck Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00971867 Org: User:
Start: 08/04/06 End: 11/26/08 Due: 11/26/09

A Study to Evaluate the Long-term Safety and Efficacy of Deucravacitinib in Participants With Crohn's Disease or Ulcerative Colitis

Phase: N/A Priority: Normal
NCT ID: NCT04877990 Org: User:
Start: 05/07/21 End: 08/29/23 Due: 08/29/24

Pharmacokinetics and Metabolism Study of Radiolabeled BMS-986142 in Healthy Male Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02880670 Org: User:
Start: 08/31/16 End: 09/30/16 Due: 09/30/17

Expanded Access Treatment Protocol CA204-143

Phase: N/A Priority: Normal
NCT ID: NCT02368301 Org: User:
Start: - End: - Due: -

Ph II of a Novel Anti-angiogenic Agent in Combination With Chemotherapy for the Treatment of Non-Small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00850577 Org: User:
Start: 06/30/09 End: 08/31/13 Due: 08/31/14